These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 9052629
1. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J. Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629 [Abstract] [Full Text] [Related]
2. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH. Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650 [Abstract] [Full Text] [Related]
3. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM, EURODIAB Prospective Complications Study. Diabetes Care; 2001 Feb; 24(2):284-9. PubMed ID: 11213880 [Abstract] [Full Text] [Related]
4. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL. Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):233-52. PubMed ID: 9477980 [Abstract] [Full Text] [Related]
5. High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention. Burgess PI, Allain TJ, García-Fiñana M, Beare NA, Msukwa G, Harding SP. Diabet Med; 2014 Dec; 31(12):1643-50. PubMed ID: 24823871 [Abstract] [Full Text] [Related]
6. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Hove MN, Kristensen JK, Lauritzen T, Bek T. Acta Ophthalmol Scand; 2004 Aug; 82(4):443-8. PubMed ID: 15291939 [Abstract] [Full Text] [Related]
7. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group. Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885 [Abstract] [Full Text] [Related]
8. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. Liu Y, Yang J, Tao L, Lv H, Jiang X, Zhang M, Li X. BMJ Open; 2017 Sep 01; 7(9):e016280. PubMed ID: 28864696 [Abstract] [Full Text] [Related]
9. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Stehouwer CD, Zellenrath P, Polak BC, Baarsma GS, Nauta JJ, Donker AJ, den Ottolander GJ. Diabetologia; 1992 Jun 01; 35(6):555-9. PubMed ID: 1612229 [Abstract] [Full Text] [Related]
10. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM. N Engl J Med; 2017 Apr 20; 376(16):1507-1516. PubMed ID: 28423305 [Abstract] [Full Text] [Related]
11. Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients. Laursen JV, Hoffmann SS, Green A, Nybo M, Sjølie AK, Grauslund J. Curr Eye Res; 2013 Jan 20; 38(1):174-9. PubMed ID: 22906118 [Abstract] [Full Text] [Related]
12. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Ebeling P, Koivisto VA. Acta Diabetol; 1997 Mar 20; 34(1):33-8. PubMed ID: 9134055 [Abstract] [Full Text] [Related]
13. Risk factors for diabetic retinopathy among Saudi diabetics. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Kangave D, Moharram OA. Int Ophthalmol; 1997 Mar 20; 22(3):155-61. PubMed ID: 10548460 [Abstract] [Full Text] [Related]
14. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ. J Diabetes Complications; 1995 Mar 20; 9(3):140-8. PubMed ID: 7548977 [Abstract] [Full Text] [Related]
15. Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study. Tan GS, Gan A, Sabanayagam C, Tham YC, Neelam K, Mitchell P, Wang JJ, Lamoureux EL, Cheng CY, Wong TY. Ophthalmology; 2018 Apr 20; 125(4):529-536. PubMed ID: 29217148 [Abstract] [Full Text] [Related]
16. Care of vision and ocular health in diabetic members of a national diabetes organization: a cross-sectional study. Sundling V, Gulbrandsen P, Jervell J, Straand J. BMC Health Serv Res; 2008 Jul 28; 8():159. PubMed ID: 18655733 [Abstract] [Full Text] [Related]
17. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. Romero P, Salvat M, Fernández J, Baget M, Martinez I. J Diabetes Complications; 2007 Jul 28; 21(2):93-100. PubMed ID: 17331857 [Abstract] [Full Text] [Related]
18. Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study. Lewis AD, Hogg RE, Chandran M, Musonda L, North L, Chakravarthy U, Sivaprasad S, Menon G. Eye (Lond); 2018 Jul 28; 32(7):1201-1208. PubMed ID: 29503450 [Abstract] [Full Text] [Related]
19. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Chaturvedi N, Stephenson JM, Fuller JH. Diabetes Care; 1995 Jun 28; 18(6):785-92. PubMed ID: 7555504 [Abstract] [Full Text] [Related]
20. Visual function in young IDDM patients over 8 years of age. A 4-year longitudinal study. North RV, Farrell U, Banford D, Jones C, Gregory JW, Butler G, Owens DR. Diabetes Care; 1997 Nov 28; 20(11):1724-30. PubMed ID: 9353616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]